Management Team

Keith Rubin, M.D.
Founder and Chief Executive Officer
Ken Solovay
Chief Operating Officer
Stephanie Noviello, M.D., M.P.H.
Chief Medical Officer
Luis Rios-Nogales, M.D., Ph.D., M.B.A.
Executive VP and Chief Development Officer

Penelope Przekop, B.S., M.S., RQAP-GCP
Executive VP, Quality & Compliance, and Data Protection Officer
André Morais Campos
Vice-President, Global Clinical Operations
Marcel Thalen, Ph.D.
Vice-President, Drug Product Development

Stanley Kim, Ph.D., Esq.
Senior Vice President, Intellectual Property and Contracts
Peter Goldstein
Executive Director, Research and Development
Ana Keiko Sekine
Executive Director, Global Clinical Operations.
David Hinkel
Executive Director, Supply Chain Operations

Marion Molina, Ph.D.
Associate Director, Regulatory Affairs
Luciana da Silva Meira Butera
Associate Manager, Clinical Process Excellence
Theressa Creighton
Associate Director, Clinical Operations
Steve Glazer, M.D.
Director, New Research Programs

Walter Greenblatt
Corporate Development
Jim Ramadei
Matthew Bross
Administrative Manager

Copyright 2013-2023 ILiAD Biotechnologies
Financial Conflict of Interest (FCOI) Policy